All terms
NMPA Innovative Medical Device Pathway
China NMPA priority pathway for innovative devices with domestic IP and clinical advantage.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
The Innovative Medical Device Special Approval procedure offers prioritized review and additional regulator engagement for devices that meet criteria for novel technology, IP, and clinical value. Roughly analogous in spirit to FDA Breakthrough.What this means in practice
Demand for the pathway has grown rapidly, but eligibility depends on domestic IP and meaningful clinical differentiation - non-trivial for foreign manufacturers.Primary references
3 sourcesLink health: 3 verified· last checked 2026-05-09
NMPA·1IMDRF·1RAPS·1
- 1
NMPAVerifiedNMPAenglish.nmpa.gov.cn
- 2
IMDRF DocumentsVerifiedIMDRFimdrf.org
- 3
RAPS Regulatory FocusVerifiedRAPSraps.org
Inline markers like [1] jump to the matching reference above.